Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
Vipul Bhatia(Fred Hutch Cancer Center), John K. Lee(University of Washington)
Cited by 118
Related Papers
Genotoxic antibody-drug conjugates combined with Bcl-xL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0